ArticleBioinformatics (Oxford, England)2026
Integrating multi-modal biological knowledge via contrastive dual-view graph learning for phosphorylation site-disease association prediction.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
motivationAccurately characterizing the associations between phosphorylation sites (psites) and diseases is essential for elucidating pathogenic mechanisms and guiding therapeutic discovery. However, existing computational approaches for phosphorylation site-disease association (PDA) prediction remain limited, as they often overlook the integration of biological knowledge across multiple modalities.
resultsWe propose CDVGL-PDA, a contrastive dual-view graph learning framework for PDA prediction. Specifically, we construct a multi-modal heterogeneous graph encompassing nine node types and ten edge types, enabling comprehensive representation of phosphorylation-centric biological networks. For phosphorylation site nodes, CDVGL-PDA incorporates sequence-derived embeddings, while disease nodes are initialized with semantic features from BioBERT. The framework then performs dual-view heterogeneous graph encoding, aligns representations through contrastive learning, and adaptively integrates them via attention-based fusion to capture informative embeddings. Extensive evaluations demonstrate CDVGL-PDA's strong predictive performance across balanced, imbalanced, and low-similarity datasets. Analysis of embeddings reveals that the model effectively captures latent biological relationships. Ablation and visualization studies validate the contributions of each module, while case studies highlight its ability to uncover potential PDAs, illustrating its promise for advancing disease mechanism research and therapeutic target discovery. AVAILABILITY AND IMPLEMENTATION: The source code and datasets for CDVGL-PDA are publicly available in the GitHub repository at https://github.com/ljquanlab/CDVGL-PDA/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.